Clinical Trial Update: Revlimid / All-Trans Retinoic Acid (ATRA) / Dexamethasone in Relapsed/Refractory Multiple Myeloma [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating lenalidomide (Revlimid) with all-trans retinoic acid (ATRA) and dexamethasone for relapsed/refractory multiple myeloma has been termi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• All-trans Retinoic Acid (all-trans retinoic acid)
• DEXAMETHASONE (Dexamethasone)
• Revlimid (lenalidomide)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Myeloma | Phase 1 | Status: TERMINATED